StockData
MeiraGTx Holdings plc logo

MeiraGTx Holdings plc (MGTX) stock

MGTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 13/3065% below fair value
$8.32−0.14 (-1.65%)

Close on Nov 18, 2026Market cap $799.08MP/E 11.7Yield –

MeiraGTx pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

MeiraGTx's pe ratio was 13.6× on Nov 11, 2026.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202613.6×–

More MeiraGTx figures

See a number that looks wrong?